精確搜索結(jié)果
- Products
- 內(nèi)容類型
- Analysis Platform
- 語(yǔ)言
- Publication Date
1 - 13 共 13 條結(jié)果
Discover Agilent's automated imaging-based method for robust analysis of CAR T cell cytotoxicity, enhancing cancer treatment efficacy and research efficiency.
Research highlight confirming the critical role of metabolic fitness in CAR-NK cells and its importance to achieve superior clinical outcomes in immunotherapy.
In this application note, Antibody Analytics (Motherwell, UK) integrates IndEx-2, an advanced in vitro cell-based platform engineered to modulate the expression of one or two target antigens across a range of biologically relevant levels, with the...
This application note describes a novel real-time co-culture assay using RTCA eSight for interrogating NK92 immune cell invasion and cytotoxicity and migratory kinetic profiles based on ECM and effects of TME.
This application note evaluates the Agilent xCELLigence RTCA eSight as a tool to monitor BiTE antibody-mediated cancer cell lysis.
xCELLigence Immunotherapy IMT Assay (anti-CD9) Tethering Kit and Sample Kit Protocol
xCELLigence Immunotherapy IMT Assay (anti-CD29) Tethering Kit and Sample Kit Protocol
xCELLigence Immunotherapy IMT Assay (anti-CD40) Tethering Kit and Sample Kit Protocol
xCELLigence Immunotherapy IMT Assay (anti-CD19) Tethering Kit and Sample Kit Protocol
xCELLigence Immunotherapy IMT Assay (anti-CD71) Tethering Kit and Sample Kit Protocol
Using the Agilent xCELLigence RTCA eSight to continuously monitor CAR T cell-mediatedkilling of cancer cells over the course of multiplae days.
Using the Agilent xCELLigence RTCA system to assess both the selectivity and potency of the TCR-engineered TILs toward HLA restricted cells.
The RTCA eSight provides automated real-time multiplexed data acquisition by both impedance and imaging to gain deeper insights into CAR-T specificity, potency, persistence, and efficiency for killing of cancer cells, all while inside your...